Impact of residual tumor cells in the stem cell collection on multiple myeloma patients receiving autologous stem cell transplantation

Autologous stem cell transplantation (ASCT) is the standard therapy for patients with transplant-eligible multiple myeloma (TEMM). However, the ideal depth of response required before ASCT and the impact of residual tumor cells in the stem cell collection (SCC) on survival remains unclear. Here we c...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jingyu, Yan, Wenqiang, Fan, Huishou, Liu, Jiahui, Li, Lingna, Du, Chenxing, Deng, Shuhui, Sui, Weiwei, Xu, Yan, Qiu, Lugui, An, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567849/
https://www.ncbi.nlm.nih.gov/pubmed/37679605
http://dx.doi.org/10.1007/s00277-023-05427-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567849/
https://www.ncbi.nlm.nih.gov/pubmed/37679605
http://dx.doi.org/10.1007/s00277-023-05427-8

Ejemplares similares